News | July 30, 2014

ACR Releases Statement on Cancer Study Regarding Patient Anxiety from CT Lung Cancer Screening

July 30, 2014 — Anxiety regarding inconclusive cancer screening test results among some patients is real and is only natural. However, as evidenced by Gareen et al, published July 25 in Cancer, the incidence and effects of anxiety associated with false positive or other results of computed tomography (CT) lung cancer screening exams are far less than claimed by some in the medical community.

“Unsubstantiated claims of systemic and harmful patient anxiety should now be put to rest and not continue to delay implementation of CT lung cancer screening programs or Medicare coverage for these tests. It is clear that the lifesaving benefit of these exams in high-risk patients far outweighs any downside,” said Ella A. Kazerooni, M.D., chair of the American College of Radiology (ACR) Lung Screening Committee.

Gareen et al found that patients who had an abnormal finding on a lung cancer screening test did not experience more anxiety or reduced quality of life than those who were screened and found to be cancer-free. Imaging experts (researchers and clinicians) and allied professionals continue to work to reduce the number of false-positive exams that patients experience and ensure that follow-up exams are as minimally invasive as possible. Physicians also continue to refine the reporting process to ensure that patients receive results as quickly as possible.

Primary National Lung Screening Trial (NLST) results showed that screening high-risk patients for lung cancer using low-dose computed tomography (CT) scans significantly reduced lung cancer deaths. The test is at least as cost-effective as other major cancer screening programs and even automobile seatbelts and airbags. In December 2013, the United States Preventive Services Task Force (USPSTF) recommended annual CT lung cancer screening for high-risk patients. Under the Affordable Care Act, private insurers are required to begin covering this service starting Jan. 1, 2015. However, Medicare is not required to follow USPSTF recommendations. CMS will make its final coverage decision in February 2015.

Significant lung cancer screening infrastructure continues to grow. The college created the ACR Lung Cancer Screening Center program, to help certify that these lifesaving exams are provided in a safe, effective manner. The ACR also launched the first edition of Lung-RADS, a quality assurance tool designed to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations and facilitate outcome monitoring.

“For the first time, we can save thousands of people each year from the nation’s leading cancer killer. Medicare coverage of these lifesaving exams would provide seniors with ready access to this care and help the medical community save lives,” said Kazerooni.

For more information: www.acr.org

Related Content

Clinical Trial Testing Topical Gel to Reduce Breast Density
News | Breast Density | June 19, 2018
Women with dense breast tissue soon might be adding a new product to their skincare routine to help them fight breast...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
PET/CT Changes Care for 59 Percent of Suspected Recurrent Prostate Cancer Cases
News | Prostate Cancer | June 13, 2018
A recently presented investigational clinical trial evaluated the impact of 18F fluciclovine positron emission...
American Society of Neuroradiology Honors Peter Chang with Cornelius G. Dyke Memorial Award
News | Neuro Imaging | June 13, 2018
Peter Chang, M.D., current neuroradiology fellow at UCSF and recently recruited co-director of the UCI Center for...
Accuray TomoTherapy System Beneficial in Two Total Body Irradiation Studies
News | Radiation Therapy | June 13, 2018
Recently published data from two new studies demonstrate the benefits of Accuray’s TomoTherapy System in the delivery...
Overlay Init